Aware (AWRE) 10-Q 31 Jul 20 2020 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2020	Jul. 31, 2020
Document and Entity Information
Entity Registrant Name	AWARE INC /MA/
Entity Central Index Key	0001015739
Trading Symbol	awre
Entity Current Reporting Status	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		21,500,239
Document Type	10-Q
Document Period End Date	Jun. 30, 2020
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Interactive Data Current	Yes

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 44,951	$ 47,742
Accounts receivable, net of allowance for doubtful accounts of $138 and $20 at June 30, 2020 and December 31, 2019, respectively	2,397	2,487
Unbilled receivables	2,018	3,315
Prepaid expenses and other current assets	265	256
Total current assets	49,631	53,800
Property and equipment, net	3,844	3,755
Long-term tax receivable	691
Total assets	54,166	57,555
Current liabilities:
Accounts payable	284	187
Accrued expenses	1,870	1,096
Deferred revenue	2,882	2,777
Total current liabilities	5,036	4,060
Long-term deferred revenue	79	60
Commitments and contingent liabilities	0	0
Stockholders' equity:
Preferred stock, $1.00 par value; 1,000,000 shares authorized, none outstanding	0	0
Common stock, $.01 par value; 70,000,000 shares authorized; issued and outstanding 21,390,466 as of June 30, 2020 and 21,442,781 as of December 31, 2019	214	214
Additional paid-in capital	96,073	96,255
Accumulated deficit	(47,236)	(43,034)
Total stockholders' equity	49,051	53,435
Total liabilities and stockholders' equity	$ 54,166	$ 57,555

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
CONSOLIDATED BALANCE SHEETS
Allowance for doubtful accounts (in dollars)	$ 138	$ 20
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	21,390,466	21,442,781
Common stock, shares outstanding	21,390,466	21,442,781

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue:
Total revenue	$ 1,890	$ 3,012	$ 5,409	$ 6,744
Costs and expenses:
Cost of services	164	321	334	839
Research and development	2,422	2,091	4,694	3,851
Selling and marketing	1,180	909	2,466	1,736
General and administrative	1,825	874	2,963	1,595
Total costs and expenses	5,591	4,195	10,457	8,021
Patent related income				49
Operating loss	(3,701)	(1,183)	(5,048)	(1,228)
Interest income	19	278	167	553
Income (loss) before provision for (benefit from) income taxes	(3,682)	(905)	(4,881)	(675)
Provision for (benefit from) income taxes	(541)	33	(680)	35
Net loss	$ (3,141)	$ (938)	$ (4,201)	$ (710)
Net loss per share - basic (in dollars per share)	$ (0.15)	$ (0.04)	$ (0.20)	$ (0.03)
Net loss per share - diluted (in dollars per share)	$ (0.15)	$ (0.04)	$ (0.20)	$ (0.03)
Weighted-average shares - basic (in shares)	21,470	21,537	21,495	21,551
Weighted-average shares - diluted (in shares)	21,470	21,537	21,495	21,551
Software licenses
Revenue:
Total revenue	$ 409	$ 1,189	$ 2,381	$ 2,725
Software maintenance
Revenue:
Total revenue	1,382	1,320	2,741	2,675
Services
Revenue:
Total revenue	$ 99	$ 503	$ 287	$ 1,344

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net loss	$ (4,201)	$ (710)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	263	221
Stock-based compensation	313	190
Deferred tax assets		(163)
Changes in assets and liabilities:
Accounts receivable	90	(926)
Unbilled receivables	1,297	(380)
Prepaid expenses and other current assets	(9)	50
Long-term tax receivable	(691)
Accounts payable	97	41
Accrued expenses	773	(90)
Accrued income taxes		124
Deferred revenue	124	(675)
Net cash used in operating activities	(1,944)	(2,318)
Cash flows from investing activities:
Purchases of property and equipment	(352)	(69)
Net cash used in investing activities	(352)	(69)
Cash flows from financing activities:
Proceeds from issuance of common stock	24	22
Payments made for taxes of employees who surrendered shares related to unrestricted stock	(50)	(49)
Repurchase of common stock	(469)	(239)
Net cash used in financing activities	(495)	(266)
Decrease in cash and cash equivalents	(2,791)	(2,653)
Cash and cash equivalents, beginning of period	47,742	51,612
Cash and cash equivalents, end of period	44,951	48,959
Supplemental disclosure:
Cash paid for income taxes	$ 1	$ 40

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 215	$ 96,376	$ (34,694)	$ 61,897
Balance (in shares) at Dec. 31, 2018	21,516,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of unrestricted stock	$ 1	(1)
Issuance of unrestricted stock (in shares)	69,000
Shares surrendered by employees to pay taxes related to unrestricted stock		(49)		(49)
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)	(14,000)
Stock-based compensation expense		14		14
Repurchase of common stock		(78)		(78)
Repurchase of common stock (in shares)	(20,000)
Net income (loss)			228	228
Balance at Mar. 31, 2019	$ 216	96,262	(34,466)	62,012
Balance (in shares) at Mar. 31, 2019	21,551,000
Balance at Dec. 31, 2018	$ 215	96,376	(34,694)	61,897
Balance (in shares) at Dec. 31, 2018	21,516,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				(710)
Balance at Jun. 30, 2019	$ 215	96,300	(35,404)	61,111
Balance (in shares) at Jun. 30, 2019	21,514,000
Balance at Mar. 31, 2019	$ 216	96,262	(34,466)	62,012
Balance (in shares) at Mar. 31, 2019	21,551,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)	4,000
Issuance of common stock under employee stock purchase plan		22		22
Issuance of common stock under employee stock purchase plan (in shares)	7,000
Stock-based compensation expense		177		177
Repurchase of common stock	$ (1)	(161)		(162)
Repurchase of common stock (in shares)	(48,000)
Net income (loss)			(938)	(938)
Balance at Jun. 30, 2019	$ 215	96,300	(35,404)	61,111
Balance (in shares) at Jun. 30, 2019	21,514,000
Balance at Dec. 31, 2019	$ 214	96,255	(43,034)	$ 53,435
Balance (in shares) at Dec. 31, 2019	21,443,000			21,442,781
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of unrestricted stock	$ 1	(1)
Issuance of unrestricted stock (in shares)	94,000
Shares surrendered by employees to pay taxes related to unrestricted stock		(50)		$ (50)
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)	(15,000)
Stock-based compensation expense		83		83
Net income (loss)			(1,060)	(1,060)
Balance at Mar. 31, 2020	$ 215	96,287	(44,094)	52,408
Balance (in shares) at Mar. 31, 2020	21,522,000
Balance at Dec. 31, 2019	$ 214	96,255	(43,034)	$ 53,435
Balance (in shares) at Dec. 31, 2019	21,443,000			21,442,781
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				$ (4,201)
Balance at Jun. 30, 2020	$ 214	96,072	(47,235)	$ 49,051
Balance (in shares) at Jun. 30, 2020	21,390,000			21,390,466
Balance at Mar. 31, 2020	$ 215	96,287	(44,094)	$ 52,408
Balance (in shares) at Mar. 31, 2020	21,522,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan		23		23
Issuance of common stock under employee stock purchase plan (in shares)	7,000
Stock-based compensation expense		230		230
Repurchase of common stock	$ (1)	(468)		$ (469)
Repurchase of common stock (in shares)	(139,000)			(139,000)
Net income (loss)			(3,141)	$ (3,141)
Balance at Jun. 30, 2020	$ 214	$ 96,072	$ (47,235)	$ 49,051
Balance (in shares) at Jun. 30, 2020	21,390,000			21,390,466

Description of the Company and

Description of the Company and Basis of Presentation	6 Months Ended
	Jun. 30, 2020
Description of the Company and Basis of Presentation
Description of the Company and Basis of Presentation	Note 1 – Description of the Company and Basis of Presentation Description of the Company We are a leading provider of software and services to the biometrics industry. Our software products are used in government and commercial biometrics systems, which are capable of determining or verifying an individual’s identity. We offer engineering services related to software configuration, integration, and installation, as well as complete systems development. We sell our biometrics software products and services globally through systems integrators, OEMs, and directly to end user customers. We also derive a portion of our revenue from the sale of imaging software. Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions for Form 10‑Q and therefore do not include all information and notes necessary for a complete presentation of our financial position, results of operations and cash flows, in conformity with generally accepted accounting principles. We filed audited financial statements which included all information and notes necessary for such presentation for the two years ended December 31, 2019 in conjunction with our 2019 Annual Report on Form 10‑K. This Form 10‑Q should be read in conjunction with that Form 10‑K. The accompanying unaudited consolidated balance sheets, statements of operations, statements of cash flows, and statements of stockholders’ equity reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at June 30, 2020, and of operations and cash flows for the interim periods ended June 30, 2020 and 2019. The results of operations for the interim period ended June 30, 2020 are not necessarily indicative of the results to be expected for the year. Principles of Consolidation The consolidated financial statements include the accounts of Aware and its subsidiary. Intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, useful lives of fixed assets, valuation allowance for deferred income tax assets, and accrued liabilities. Actual results could differ from those estimates. Recent Accounting Pronouncements In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . The ASU was issued to reduce the complexity of the reporting information for financial statement users. We adopted the standard on January 1, 2020. The adoption of the standard did not result in any adjustment to our financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments , which changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. This guidance was to be effective for reporting periods beginning after December 15, 2019, with early adoption permitted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) Effective Dates, which deferred the effective dates for us, as a smaller reporting company, until fiscal year 2023. We are continuing to assess the impact of the standard on our consolidated financial statements.

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2020
Revenue Recognition
Revenue Recognition	Note 2 – Revenue Recognition We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, we apply the following five step model: 1. Identify the contract with the customer; 2. Identify the performance obligations in the contract; 3. Determine the transaction price; 4. Allocate the transaction price to the performance obligations in the contract; and 5. Recognize revenue when (or as) each performance obligation is satisfied. We categorize revenue as software licenses, software maintenance, or services. Revenue from software licenses is recognized at a point in time upon delivery, provided all other revenue recognition criteria are met. We recognize software maintenance revenue over time on a straight-line basis over the contract period. Services revenue is recognized over time as the services are delivered using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted), provided all other revenue recognition criteria are met. In addition to selling software licenses, software maintenance and software services on a standalone basis, a significant portion of our contracts include multiple performance obligations, which require an allocation of the transaction price to each performance obligation based on a relative standalone selling price (“SSP”) basis. In addition to selling software licenses, software maintenance and software services on a standalone basis, a significant portion of our contracts include multiple performance obligations, which require an allocation of the transaction price to each distinct performance obligation based on a relative standalone selling price (“SSP) basis. The SSP is the price at which we would sell a promised good or service separately to a customer. The best estimate of SSP is the observable price of a good or service when we sell that good or service separately. A contractually stated price or a list price for a good or service may be the SSP of that good or service. We use a range of amounts to estimate SSP when we sell each of the goods and services separately and need to determine whether there is a discount that needs to be allocated based on the relative SSP of the various goods and services. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, we typically determine the SSP using an adjusted market assessment approach using information that may include market conditions and other observable inputs. We typically have more than one SSP for individual goods and services due to the stratification of those goods and services by customers and circumstances. In these instances, we may use information such as the nature of the customer and distribution channel in determining the SSP. When software licenses and significant customization engineering services are sold together, they are accounted for as a combined performance obligation, as the software licenses are generally highly dependent on, and interrelated with, the associated customization services and therefore are not distinct performance obligations. Revenue for the combined performance obligation is recognized over time as the services are delivered using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted). The amount of consideration is not adjusted for a significant financing component if the time between payment and the transfer of the related good or service is expected to be one year or less under the practical expedient in ASC 606-10-32-18. Our revenue arrangements are typically accounted for under such expedient, as payment is typically due within 30 to 60 days. As of June 30, 2020 and 2019, none of our contracts contained a significant financing component. Disaggregation of Revenues We organize ourselves into a single segment that reports to the chief operating decision maker. We conduct our operations in the United States and sell our products and services to domestic and international customers. Revenues were generated from the following geographic regions for the three and six months ended June 30, 2020 and 2019 (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 United States $ 1,156 $ 1,728 $ 3,167 $ 3,451 United Kingdom 92 466 779 1,345 Brazil 210 177 491 330 Canada 199 84 337 311 Rest of World 233 557 635 1,307 $ 1,890 $ 3,012 $ 5,409 $ 6,744 Revenue by product group for the three and six months ended June 30, 2020 and 2019 was (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Biometrics $ 1,709 $ 2,877 $ 4,971 $ 6,349 Imaging 181 135 438 395 $ 1,890 $ 3,012 $ 5,409 $ 6,744 Revenue by timing of transfer of goods or services for the three and six months ended June 30, 2020 and 2019 was (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Goods or services transferred at a point in time $ 409 $ 957 $ 2,362 $ 2,128 Goods or services transferred over time 1,481 2,055 3,047 4,616 $ 1,890 $ 3,012 $ 5,409 $ 6,744 Contract Balances When the timing of our delivery of goods or services is different from the timing of payments made by customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance). Customers that prepay are represented by the deferred revenue below until the performance obligation is satisfied. Our contract assets consist of unbilled receivables. Our contract liabilities consist of deferred (unearned) revenue, which is generally related to software maintenance contracts. We classify deferred revenue as current or noncurrent based on the timing of when we expect to recognize revenue. The following table presents changes in our contract assets and liabilities during the six months ended June 30, 2019 and 2020 (in thousands): Revenue Balance at Recognized Beginning of In Advance of Balance at End of Period Billings Billings Period Three months ended June 30, 2019 Contract assets: Unbilled receivables $ 3,918 $ 409 $ (668) $ 3,659 Three months ended June 30, 2020 Contract assets: Unbilled receivables $ 3,225 $ 77 $ (1,284) $ 2,018 Balance at Beginning of Revenue Balance at End of Period Billings Recognized Period Three months ended June 30, 2019 Contract liabilities: Deferred revenue $ 2,516 $ 1,228 $ (1,320) $ 2,424 Three months ended June 30, 2020 Contract liabilities: Deferred revenue $ 2,617 $ 1,736 $ (1,392) $ 2,961 Revenue Balance at Recognized Beginning of In Advance of Balance at End of Period Billings Billings Period Six months ended June 30, 2019 Contract assets: Unbilled receivables $ 3,279 $ 1,468 $ (1,088) $ 3,659 Six months ended June 30, 2020 Contract assets: Unbilled receivables $ 3,315 $ 260 $ (1,557) $ 2,018 Balance at Beginning of Revenue Balance at End of Period Billings Recognized Period Six months ended June 30, 2019 Contract liabilities: Deferred revenue $ 3,099 $ 2,000 $ (2,675) $ 2,424 Six months ended June 30, 2020 Contract liabilities: Deferred revenue $ 2,837 $ 2,884 $ (2,760) $ 2,961 Remaining Performance Obligations Remaining performance obligations represent the transaction price from contracts for which work has not been performed or goods and services have not been delivered. We expect to recognize revenue on approximately 58% of the remaining performance obligations over the next 12 months, with the remainder recognized thereafter. As of June 30, 2020, the aggregate amount of the transaction price allocated to remaining performance obligations for software maintenance contracts with a duration greater than one year was $2.6 million.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2020
Fair Value Measurements
Fair Value Measurements	Note 3 – Fair Value Measurements The Financial Accounting Standards Board (“FASB”) Codification defines fair value, and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels of the fair value hierarchy under the FASB Codification are: i) Level 1 – valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date; ii) Level 2 – valuations that are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and iii) Level 3 – valuations that require inputs that are both significant to the fair value measurement and unobservable. Cash and cash equivalents, which primarily include money market mutual funds, were $45.0 million and $47.7 million as of June 30, 2020 and December 31, 2019, respectively. As of June 30, 2020, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values included the following (in thousands): Fair Value Measurement at June 30, 2020 Using: Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (Level 1) (Level 2) (Level 3) Money market funds (included in cash and cash equivalents) $ 43,740 $ — $ — Total $ 43,740 $ — $ — As of December 31, 2019, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values included the following (in thousands): Fair Value Measurement at December 31, 2019 Using: Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (Level 1) (Level 2) (Level 3) Money market funds (included in cash and cash equivalents) $ 46,174 $ — $ — Total $ 46,174 $ — $ —

Computation of Earnings per Sha

Computation of Earnings per Share	6 Months Ended
	Jun. 30, 2020
Computation of Earnings per Share
Computation of Earnings per Share	Note 4 – Computation of Earnings per Share Basic earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding plus additional common shares that would have been outstanding if dilutive potential common shares had been issued. For the purposes of this calculation, stock options are considered common stock equivalents in periods in which they have a dilutive effect. Stock options that are anti-dilutive are excluded from the calculation. Potential common stock equivalents were not included in the per share calculation for diluted earnings per share, because we had a net loss and the effect of their inclusion would be anti -dilutive. Net income (loss) per share is calculated as follows (in thousands, except per share data): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Net loss $ (3,141) $ (938) $ (4,201) $ (710) Shares outstanding : Weighted-average common shares outstanding 21,470 21,537 21,495 21,551 Additional dilutive common stock equivalents — — — — Diluted shares outstanding 21,470 21,537 21,495 21,551 Net loss per share – basic $ (0.15) $ (0.04) $ (0.20) $ (0.03) Net loss per share - diluted $ (0.15) $ (0.04) $ (0.20) $ (0.03)

Stock-based Compensation

Stock-based Compensation	6 Months Ended
	Jun. 30, 2020
Stock-based Compensation
Stock-based Compensation	Note 5 – Stock-based compensation The following table presents stock-based employee compensation expenses included in our unaudited consolidated statements of comprehensive income (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Cost of services $ 4 $ 7 $ 5 $ 8 Research and development 52 36 56 38 Selling and marketing 48 4 73 4 General and administrative 126 130 179 140 Stock-based compensation expense $ 230 $ 177 $ 313 $ 190 Stock Options. We granted stock options for 50,000 shares in the three and six months ended June 30, 2020 and no shares in the three and six months ended June 30, 2019. Unrestricted Stock Grants . We grant unrestricted shares of stock under our 2001 Nonqualified Stock Plan. Stock-based compensation expense for stock grants is determined based on the fair market value of our stock on the date of grant, provided the number of shares in the grant is fixed on the grant date. We granted shares of unrestricted stock in 2020 and 2019 that affected financial results for the three and six month periods ended June 30, 2020 and 2019. These grants are described below. For the three and six months ended June 30, 2020 we granted 33,000 and 243,000 shares of unrestricted stock to directors, officers, and employees, respectively. The shares will be issued in two equal installments shortly after June 30, 2020 and December 31, 2020, provided each grantee is serving as a director, officer or employee on those dates. The total stock-based compensation expense related to these grants is $0.7 million, of which $0.2 million was charged to expense in the six months ended June 30, 2020. We anticipate the remaining $0.5 million will be charged to expense ratably over the remaining two quarters of 2020. In 2019 we granted 285,500 shares of unrestricted stock to directors, officers, and employees. We granted 120,000 shares which will be issued in four equal installments on their anniversary in September and October of 2020, 2021, 2022, and 2023, provided the grantee is serving as a director, officer, or employee on those dates. We also granted 165,500 shares throughout March, September, and October of 2019. We issued 71,500 and 94,000 shares shortly after June 30 2019 and December 31, 2019, respectively. The total stock-based compensation expense related to the 285,500 shares granted in 2019 is $947,000, of which $633,000 was charged to expense in the 2019 and $42,000 was charged to expense in six months ended June 30, 2020. We anticipate the remaining $272,000 will be charged to expense ratably through 2023. We issued shares of common stock related to the March 2019 grant as follows: i) 58,548 net shares of common stock were issued in early July 2019 after employees surrendered 12,952 shares for which we paid $43,000 of withholding taxes on their behalf; and ii) 56,605 net shares of common stock were issued in early January 2020 after employees surrendered 14,895 shares for which we paid $50,000 of withholding taxes on their behalf. Performance Share Award . In September 2019, we granted 20,000 shares of stock to an officer as a performance share award under our 2001 Nonqualified Stock Plan. The shares were issued in September 2019 and were forfeitable if the grantee was not serving as a director, officer or employee on March 19, 2020. Stock-based compensation expense for this stock grant was determined based on the fair market value of our stock on the date of grant, as the number of shares in the grant was fixed on the grant date. The total stock-based compensation expense related to this grant was $55,000, of which $31,000 was charged to expense in 2019 and $24,000 was charged to expense in the six months ended June 30, 2020. In October 2019, we granted 10,000 shares of stock to an officer as a performance share award under our 2001 Nonqualified Stock Plan. The shares were issued in October 2019 and were forfeitable if the grantee was not serving as a director, officer or employee on April 1, 2020. Stock-based compensation expense for this stock grant was determined based on the fair market value of our stock on the date of grant, as the number of shares in the grant was fixed on the grant date. The total stock-based compensation expense related to this grant was $29,000, of which $15,000 was charged to expense in 2019 and $14,000 was charged to expense in the six months ended June 30, 2020.

Stock Repurchase Program

Stock Repurchase Program	6 Months Ended
	Jun. 30, 2020
Stock Repurchase Program
Stock Repurchase Program	Note 6 – Stock Repurchase Program On April 30, 2020, the Board of Directors approved a program authorizing the Company to purchase up to $10 million of its common stock of which $0.5 million had been utilized as of June 30, 2020. During the three months ended June 30, 2020, the Company repurchased 139,000 shares of its common stock for $0.5 million. The shares may be purchased from time to time in the open market or through privately negotiated transactions at management’s discretion, depending upon market conditions and other factors. The authorization to repurchase Company stock expires on December 31, 2021. Repurchases will be made under the program using the Company’s own cash resources and will been accordance with Rule 10b-18 under the Securities Exchange Act of 1934 and other applicable laws, rules and regulations. The program does not obligate the Company to acquire any particular amount of common stock and the program may be modified or suspended at any time at the Company’s discretion.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2020
Income Taxes
Income Taxes	Note 7 - Income Taxes Income tax benefit was $0.5 million and $0.7 million for the three and six months ended June 30, 2020, respectively. Income tax expense for the three and six month periods ended June 30, 2020 were based on the U.S. statutory rate of 21%, increased by state income taxes, and reduced by permanent adjustments and research tax credits. The Coronavirus Aid, Relief and Economic Security Act (CARES Act) was signed into law on March 27, 2020. The CARES Act contained specific relief and stimulus measures including allowing net operating losses originating in 2018 through 2020 to be carried back five years to offset taxable income in the carryback period. Separately, the enactment of the Tax Cut and Jobs Act in 2017 allowed taxpayers to claim a refund for alternative minimum tax credits over a period of years. The CARES Act enacted during the first quarter of 2020 allows for the entire amount of the credit to be refunded in 2020. We have reviewed the impact of the CARES Act enactment on the income tax provision and have determined that, as a result of the net operating loss carryback provision, we can obtain a tax benefit if we were to carry back the forecasted 2020 net operating loss to the five year carryback period. The carryback of the estimated loss would result in a refundable alternative minimum tax credit of approximately $1.2 million and an increase in research credit carryforwards previously utilized. The alternative minimum tax credit can be refunded in the future, if we decide to carry back the loss reported on the filed 2020 tax return instead of electing to carry the loss forward. Due to the recent loss history, continued investments in the company, and our future projections of income, we will benefit from the current year loss to the extent of the available tax refund and will maintain a full valuation allowance on all other deferred tax assets, including any increase in research credit carryforward resulting from a potential carryback. As of the end of the period, we have not made a determination on whether to elect to carry forward the 2020 operating loss, however, the alternative minimum tax refund potential on carryback represents a minimum tax benefit we can obtain from the estimated 2020 loss. We can realize a tax benefit to the extent of the carryback refund potential as it is considered a source of income against which to utilize the 2020 estimated loss. The total estimated benefit of the alternative minimum tax refund of $1.2 million is included in our projection of our annual effective rate and results in a year to date benefit of approximately $0.7 million. We recorded the year to date tax benefit as a long term tax receivable.

Description of the Company an_2

Description of the Company and Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2020
Description of the Company and Basis of Presentation
Basis of Presentation	Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions for Form 10‑Q and therefore do not include all information and notes necessary for a complete presentation of our financial position, results of operations and cash flows, in conformity with generally accepted accounting principles. We filed audited financial statements which included all information and notes necessary for such presentation for the two years ended December 31, 2019 in conjunction with our 2019 Annual Report on Form 10‑K. This Form 10‑Q should be read in conjunction with that Form 10‑K. The accompanying unaudited consolidated balance sheets, statements of operations, statements of cash flows, and statements of stockholders’ equity reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at June 30, 2020, and of operations and cash flows for the interim periods ended June 30, 2020 and 2019. The results of operations for the interim period ended June 30, 2020 are not necessarily indicative of the results to be expected for the year.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Aware and its subsidiary. Intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, useful lives of fixed assets, valuation allowance for deferred income tax assets, and accrued liabilities. Actual results could differ from those estimates.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . The ASU was issued to reduce the complexity of the reporting information for financial statement users. We adopted the standard on January 1, 2020. The adoption of the standard did not result in any adjustment to our financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments , which changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. This guidance was to be effective for reporting periods beginning after December 15, 2019, with early adoption permitted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) Effective Dates, which deferred the effective dates for us, as a smaller reporting company, until fiscal year 2023. We are continuing to assess the impact of the standard on our consolidated financial statements.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2020
Revenue Recognition
Schedule of revenues generated from geographic regions	Revenues were generated from the following geographic regions for the three and six months ended June 30, 2020 and 2019 (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 United States $ 1,156 $ 1,728 $ 3,167 $ 3,451 United Kingdom 92 466 779 1,345 Brazil 210 177 491 330 Canada 199 84 337 311 Rest of World 233 557 635 1,307 $ 1,890 $ 3,012 $ 5,409 $ 6,744
Schedule of revenue by product group	Revenue by product group for the three and six months ended June 30, 2020 and 2019 was (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Biometrics $ 1,709 $ 2,877 $ 4,971 $ 6,349 Imaging 181 135 438 395 $ 1,890 $ 3,012 $ 5,409 $ 6,744
Schedule of revenue by timing of transfer of goods or services	Revenue by timing of transfer of goods or services for the three and six months ended June 30, 2020 and 2019 was (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Goods or services transferred at a point in time $ 409 $ 957 $ 2,362 $ 2,128 Goods or services transferred over time 1,481 2,055 3,047 4,616 $ 1,890 $ 3,012 $ 5,409 $ 6,744
Schedule of changes in contract assets and liabilities	The following table presents changes in our contract assets and liabilities during the six months ended June 30, 2019 and 2020 (in thousands): Revenue Balance at Recognized Beginning of In Advance of Balance at End of Period Billings Billings Period Three months ended June 30, 2019 Contract assets: Unbilled receivables $ 3,918 $ 409 $ (668) $ 3,659 Three months ended June 30, 2020 Contract assets: Unbilled receivables $ 3,225 $ 77 $ (1,284) $ 2,018 Balance at Beginning of Revenue Balance at End of Period Billings Recognized Period Three months ended June 30, 2019 Contract liabilities: Deferred revenue $ 2,516 $ 1,228 $ (1,320) $ 2,424 Three months ended June 30, 2020 Contract liabilities: Deferred revenue $ 2,617 $ 1,736 $ (1,392) $ 2,961 Revenue Balance at Recognized Beginning of In Advance of Balance at End of Period Billings Billings Period Six months ended June 30, 2019 Contract assets: Unbilled receivables $ 3,279 $ 1,468 $ (1,088) $ 3,659 Six months ended June 30, 2020 Contract assets: Unbilled receivables $ 3,315 $ 260 $ (1,557) $ 2,018 Balance at Beginning of Revenue Balance at End of Period Billings Recognized Period Six months ended June 30, 2019 Contract liabilities: Deferred revenue $ 3,099 $ 2,000 $ (2,675) $ 2,424 Six months ended June 30, 2020 Contract liabilities: Deferred revenue $ 2,837 $ 2,884 $ (2,760) $ 2,961

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2020
Fair Value Measurements
Schedule of assets measured at fair value on a recurring basis	As of June 30, 2020, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values included the following (in thousands): Fair Value Measurement at June 30, 2020 Using: Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (Level 1) (Level 2) (Level 3) Money market funds (included in cash and cash equivalents) $ 43,740 $ — $ — Total $ 43,740 $ — $ — As of December 31, 2019, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values included the following (in thousands): Fair Value Measurement at December 31, 2019 Using: Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (Level 1) (Level 2) (Level 3) Money market funds (included in cash and cash equivalents) $ 46,174 $ — $ — Total $ 46,174 $ — $ —

Computation of Earnings per S_2

Computation of Earnings per Share (Tables)	6 Months Ended
	Jun. 30, 2020
Computation of Earnings per Share
Schedule of net loss per share	Net income (loss) per share is calculated as follows (in thousands, except per share data): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Net loss $ (3,141) $ (938) $ (4,201) $ (710) Shares outstanding : Weighted-average common shares outstanding 21,470 21,537 21,495 21,551 Additional dilutive common stock equivalents — — — — Diluted shares outstanding 21,470 21,537 21,495 21,551 Net loss per share – basic $ (0.15) $ (0.04) $ (0.20) $ (0.03) Net loss per share - diluted $ (0.15) $ (0.04) $ (0.20) $ (0.03)

Stock-based Compensation (Table

Stock-based Compensation (Tables)	6 Months Ended
	Jun. 30, 2020
Stock-based Compensation
Schedule of stock-based employee compensation expense included in unaudited consolidated statements of comprehensive income	The following table presents stock-based employee compensation expenses included in our unaudited consolidated statements of comprehensive income (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2020 2019 2020 2019 Cost of services $ 4 $ 7 $ 5 $ 8 Research and development 52 36 56 38 Selling and marketing 48 4 73 4 General and administrative 126 130 179 140 Stock-based compensation expense $ 230 $ 177 $ 313 $ 190

Revenue Recognition - Revenues

Revenue Recognition - Revenues generated following geographic regions (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,890	$ 3,012	$ 5,409	$ 6,744
Operating Segments | United States
Disaggregation of Revenue [Line Items]
Total revenue	1,156	1,728	3,167	3,451
Operating Segments | United Kingdom
Disaggregation of Revenue [Line Items]
Total revenue	92	466	779	1,345
Operating Segments | Brazil
Disaggregation of Revenue [Line Items]
Total revenue	210	177	491	330
Operating Segments | Canada
Disaggregation of Revenue [Line Items]
Total revenue	199	84	337	311
Operating Segments | Rest of World
Disaggregation of Revenue [Line Items]
Total revenue	$ 233	$ 557	$ 635	$ 1,307

Revenue Recognition - Summary o

Revenue Recognition - Summary of revenue by product group (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,890	$ 3,012	$ 5,409	$ 6,744
Operating Segments | Biometrics
Disaggregation of Revenue [Line Items]
Total revenue	1,709	2,877	4,971	6,349
Operating Segments | Imaging
Disaggregation of Revenue [Line Items]
Total revenue	$ 181	$ 135	$ 438	$ 395

Revenue Recognition - Revenue b

Revenue Recognition - Revenue by timing of transfer of goods or services (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,890	$ 3,012	$ 5,409	$ 6,744
Goods or services transferred at a point in time
Disaggregation of Revenue [Line Items]
Total revenue	409	957	2,362	2,128
Goods or services transferred over time
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,481	$ 2,055	$ 3,047	$ 4,616

Revenue Recognition - Changes i

Revenue Recognition - Changes in contract assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Contract assets:
Unbilled receivables, Balance at Beginning of Period	$ 3,225	$ 3,918	$ 3,315	$ 3,279
Unbilled receivables, Revenue Recognized In Advance of Billings	77	409	260	1,468
Unbilled receivables, Billings	(1,284)	(668)	(1,557)	(1,088)
Unbilled receivables, Balance at End of Period	$ 2,018	$ 3,659	$ 2,018	$ 3,659

Revenue Recognition - Changes_2

Revenue Recognition - Changes in contract liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Contract liabilities:
Deferred revenue, Balance at Beginning of Period	$ 2,617	$ 2,516	$ 2,837	$ 3,099
Deferred revenue, Billings	1,736	1,228	2,884	2,000
Deferred revenue, Revenue Recognized	(1,392)	(1,320)	(2,760)	(2,675)
Deferred revenue, Balance at End of Period	$ 2,961	$ 2,424	$ 2,961	$ 2,424

Revenue Recognition - Additiona

Revenue Recognition - Additional information (Details) $ in Millions	6 Months Ended
	Jun. 30, 2020USD ($)
Disaggregation of Revenue [Line Items]
Percentage of remaining performance obligations expected to be recognized as revenue	58.00%
Minimum period of remaining performance obligations	12 months
Revenue recognition performance obligation transaction price	$ 2.6
Minimum
Disaggregation of Revenue [Line Items]
Minimum period of remaining performance obligations	30 days
Maximum
Disaggregation of Revenue [Line Items]
Minimum period of remaining performance obligations	60 days

Fair Value Measurements - Asset

Fair Value Measurements - Assets measured at fair value on a recurring basis (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Quoted Prices in Active Markets for Identical Assets (Level 1)
Schedule of Available-for-sale Securities
Total	$ 43,740	$ 46,174
Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds (included in cash and cash equivalents)
Schedule of Available-for-sale Securities
Money market funds (included in cash and cash equivalents)	43,740	46,174
Significant Other Observable Inputs (Level 2)
Schedule of Available-for-sale Securities
Total	0	0
Significant Other Observable Inputs (Level 2) | Money market funds (included in cash and cash equivalents)
Schedule of Available-for-sale Securities
Money market funds (included in cash and cash equivalents)	0	0
Significant Unobservable Inputs (Level 3)
Schedule of Available-for-sale Securities
Total	0	0
Significant Unobservable Inputs (Level 3) | Money market funds (included in cash and cash equivalents)
Schedule of Available-for-sale Securities
Money market funds (included in cash and cash equivalents)	$ 0	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional information (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Fair Value Measurements
Cash and cash equivalents, primarily include money market funds	$ 44,951	$ 47,742	$ 48,959	$ 51,612

Computation of Earnings per S_3

Computation of Earnings per Share - Net loss per share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019
Computation of Earnings per Share
Net loss	$ (3,141)	$ (1,060)	$ (938)	$ 228	$ (4,201)	$ (710)
Shares outstanding:
Weighted-average common shares outstanding (in shares)	21,470		21,537		21,495	21,551
Diluted shares outstanding (in shares)	21,470		21,537		21,495	21,551
Net loss per share - basic (in dollars per share)	$ (0.15)		$ (0.04)		$ (0.20)	$ (0.03)
Net loss per share - diluted (in dollars per share)	$ (0.15)		$ (0.04)		$ (0.20)	$ (0.03)

Stock-based Compensation - Summ

Stock-based Compensation - Summary of stock-based employee compensation expenses (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 230	$ 177	$ 313	$ 190
Cost of services
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	4	7	5	8
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	52	36	56	38
Selling and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	48	4	73	4
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 126	$ 130	$ 179	$ 140

Stock-based Compensation - Stoc

Stock-based Compensation - Stock Option Grants and Unrestricted Stock Grants (Details)	Dec. 31, 2019shares	Jun. 30, 2019shares	Jan. 31, 2020USD ($)shares	Oct. 31, 2019shares	Sep. 30, 2019shares	Jul. 31, 2019USD ($)shares	Mar. 31, 2019shares	Jun. 30, 2020USD ($)shares	Jun. 30, 2019USD ($)shares	Jun. 30, 2020USD ($)installmentshares	Jun. 30, 2019USD ($)shares	Dec. 31, 2019USD ($)installmentshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted								50,000	0	50,000	0
Total stock-based compensation expense | $								$ 230,000	$ 177,000	$ 313,000	$ 190,000
2001 Nonqualified Stock Plan | 2019 Grant
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of unrestricted stock granted				165,500	165,500		165,500
2001 Nonqualified Stock Plan | March 2019 Grant | Directors, officers and employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted			56,605			58,548
Number of common stock shares surrendered by employees withholding taxes			14,895			12,952
Common stock value surrendered by employees withholding taxes | $			$ 50,000			$ 43,000
2001 Nonqualified Stock Plan | Unrestricted Stock | Directors, officers and employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of unrestricted stock granted								33,000		243,000
Number of installment | installment										2
Total stock-based compensation expense | $										$ 700,000
Stock-based compensation expense charged to expense | $										200,000
Remaining stock based compensation expense | $								$ 500,000		500,000
2001 Nonqualified Stock Plan | Unrestricted Stock | 2019 Grant | Directors, officers and employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of unrestricted stock granted												285,500
Number of unrestricted shares issued	94,000	71,500
Number of installment | installment												4
Total stock-based compensation expense | $												$ 947,000
Stock-based compensation expense charged to expense | $										42,000		$ 633,000
Remaining stock based compensation expense | $								$ 272,000		$ 272,000
2001 Nonqualified Stock Plan | Unrestricted Stock | Grant 2019 One | Directors, officers and employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of unrestricted stock granted												285,500
2001 Nonqualified Stock Plan | Unrestricted Stock | Grant 2019 Two | Directors, officers and employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of unrestricted stock granted												120,000

Stock-based Compensation - Perf

Stock-based Compensation - Performance Share Award (Details) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	Oct. 31, 2019	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Total stock-based compensation expense			$ 230,000	$ 177,000	$ 313,000	$ 190,000
Performance Share Awards | 2001 Nonqualified Stock Plan | Officer
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Number of shares granted		20,000
Total stock-based compensation expense					24,000		$ 31,000
Share Based Compensation Expense for the Total Grant		$ 55,000
October 2019 Grant | Performance Share Awards | 2001 Nonqualified Stock Plan | Officer
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Number of shares granted	10,000
Total stock-based compensation expense					$ 14,000		$ 15,000
Share Based Compensation Expense for the Total Grant	$ 29,000

Stock Repurchase Program (Detai

Stock Repurchase Program (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Apr. 30, 2020
Stock Repurchase Program
Number of common stock authorized for repurchase					$ 10,000
Amount utilized under the program				$ 500
Number of shares repurchased during period	139,000
Value of shares repurchased	$ 469	$ 162	$ 78

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Taxes
Income tax expense (Benefit)	$ (541)	$ 33	$ (680)	$ 35
U.S. statutory rate	21.00%		21.00%
Estimated aggregate alternative minimum tax refund receivable	$ 1,200		$ 1,200
Alternative minimum tax refund receivable recorded	$ 691		$ 691